To conclude, our work contributes to the existing literature by demonstrating that the protective effects of KL-VSHET+ extend to AD-related Aβ, Tau, and pTau endophenotypes and deficits in memory and executive function in cognitively normal APOE ε4-carriers who are at risk for developing AD. The gene discussed is MAPT; the disease is Alzheimer disease.